Influence of the scan time point when assessing hypoxia in 18F-fluoromisonidazole PET: 2 vs. 4 h-Reference-Cited by-同舟云学术

Influence of the scan time point when assessing hypoxia in 18F-fluoromisonidazole PET: 2 vs. 4 h

Published:2019-11-28 Issue:8 Volume:47 Page:1833-1842
ISSN:1619-7070
Container-title:European Journal of Nuclear Medicine and Molecular Imaging
language:en
Short-container-title:Eur J Nucl Med Mol Imaging

Author:

Kobayashi Kentaro,Manabe Osamu,Hirata Kenji^ORCID,Yamaguchi Shigeru,Kobayashi Hiroyuki,Terasaka Shunsuke,Toyonaga Takuya,Furuya Sho,Magota Keiichi,Kuge Yuji,Kudo Kohsuke,Shiga Tohru,Tamaki Nagara

Publisher

Springer Science and Business Media LLC

Subject

Radiology, Nuclear Medicine and imaging,General Medicine,Radiology, Nuclear Medicine and imaging,General Medicine

Link

http://link.springer.com/content/pdf/10.1007/s00259-019-04626-8.pdf

Reference44 articles.

1. Hirata K, Yamaguchi S, Shiga T, Kuge Y, Tamaki N. The roles of hypoxia imaging using (18)F-fluoromisonidazole positron emission tomography in glioma treatment. J Clin Med. 2019;8. https://doi.org/10.3390/jcm8081088.

2. Tamaki N, Hirata K. Tumor hypoxia: a new PET imaging biomarker in clinical oncology. Int J Clin Oncol. 2016;21:619–25. https://doi.org/10.1007/s10147-015-0920-6.

3. Kobayashi H, Hirata K, Yamaguchi S, Terasaka S, Shiga T, Houkin K. Usefulness of FMISO-PET for glioma analysis. Neurol Med Chir. 2013;53:773–8. https://doi.org/10.2176/nmc.ra2013-0256.

4. Janssen HL, Haustermans KM, Balm AJ, Begg AC. Hypoxia in head and neck cancer: how much, how important? Head Neck. 2005;27:622–38. https://doi.org/10.1002/hed.20223.

5. Eschmann SM, Paulsen F, Bedeshem C, Machulla HJ, Hehr T, Bamberg M, et al. Hypoxia-imaging with (18)F-misonidazole and PET: changes of kinetics during radiotherapy of head-and-neck cancer. Radiother Oncol. 2007;83:406–10. https://doi.org/10.1016/j.radonc.2007.05.014.

Cited by 9 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Identifying G6PC3 as a Potential Key Molecule in Hypoxic Glucose Metabolism of Glioblastoma Derived from the Depiction of 18F-Fluoromisonidazole and 18F-Fluorodeoxyglucose Positron Emission Tomography;BioMed Research International;2024-02-28

2. A Review of Hypoxia Imaging Using 18F-Fluoromisonidazole Positron Emission Tomography;Methods in Molecular Biology;2024

3. New Radiopharmaceuticals for Brain Tumors Imaging;Advanced Imaging and Therapy in Neuro-Oncology;2024

4. PET Agents for Primary Brain Tumor Imaging;PET Agents for Primary Brain Tumor Imaging;2023-12-21

5. Timing of hypoxia PET/CT imaging after 18F-fluoromisonidazole injection in non-small cell lung cancer patients;Scientific Reports;2022-12-16